FDA U.S. agent (U.S. Agent) is the United States contact or service point designated by the facility or manufacturer under the applicable rules. Food, medicine, medical device, cosmetics and radiation-launched electronics are based on different methods than those specified, and processes in one industry cannot be applied directly to other industries.

Two things to confirm first:Are your business subject to the appointment of an agent, and what kind of duties the agent is responsible for. The designation of U.S. agent does not amount to obtaining an FDA approval and does not automatically replace the compliance obligations of the importer, the party responsible for the product or the enterprise itself.

I. Which enterprises need to designate FDA U.S. agent?

The use and type of product is to be determined and the manufacturing, processing, packaging and storage activities carried out by the facility are to be confirmed, together with the applicable registration or declaration requirements. Traders, branders or importers alone cannot directly introduce the same agent obligations as offshore production facilities.

Food: in combination with offshore food facilities

U.S. agent should be provided in the register for offshore food facilities requiring registration with the FDA. The agent is required to reside or have a place of business in the United States and is physically located in the United States and undertakes routine and emergency communication between the FDA and the offshore facility. The need for registration should first be checked against facility activities and applicable exemptions, and cannot be judged solely on the basis of “export food”.

Food facilities U.S. agents have different roles to play with FSVP importers. Even if the relevant services are provided by the same institution, the principal qualifications, delegation of authority and scope of responsibility should be identified separately. I'll see you in a minute.Food facilities U.S. agency servicesandFSVP Statement of importer’s responsibility。

Drugs: in combination with offshore drug facilities

For offshore pharmaceutical facilities applying 21 CFR Part 207, a U.S. agent shall be designated by 21 CFR 207.69. It should reside or have a place of business in the United States and cannot be merely a mailbox or an answer service that is not physically present; This involves assisting the FDA to communicate with the facility, as well as related inspections, recalls, etc.

U.S. agent, registered official contact person and product labeler may be carried out by different subjects. Roles should be checked on a case-by-case basis, rather than using proxy designation as an alternative to NDC, Drug Listing or listing applications. See range of services.U.S. agent services。

Medical practice: designation and consent confirmation in establishment registration

U.S. agent is required to designate U.S. agent in the business register for a facility outside the relevant country, and each facility can only designate one. The agent assists the FDA in communicating with the facility, answering questions about imported devices and arranging inspections; Should reside or have a place of business in the United States and cannot use only the postal mailbox or telephone response service.

FDA sends a request for confirmation to the designated agent. If the agent refuses or fails to respond within 10 working days, the facility is notified and has to be designated separately. In accordance with this statutory role, the agent is not responsible for the report or submission of the MDR incident 510(k); The additional task should be clearly and separately mandated and accountable. For further details, seeMedical service U.S. services。

Cosmetics: to judge the applicability of MoCRA registration

U.S. agent information should be provided for foreign cosmetics facilities that require registration with MoCRA. The agent should reside or have a place of business in the United States and be physically located in the United States, and cannot simply be a mailbox or an answer service in the absence of an actual presence. Whether registration exemptions are involved should be checked against products, facility activities and applicable conditions.

The facility U.S. agent should be identified separately from the product Responsible Person; The latter concerns the subject matter and the corresponding product obligations indicated in the label, which cannot be deemed to have been transferred by the designated agent. CombinableMake-up U.S. agent serviceandMoCRA Guide to Registration and ListingPreparation of information.

Radiation-launched electronic products: Note that legal instruments are delivered to agents

For imported electronic products subject to the radiation control rules for electronic products, 21 CFR 1005.25 requires manufacturers to appoint agents from the United States prior to the supply of the product. Written designations and declarations of acceptance are specifically required and cannot be concluded by filling in only one contact person, nor can they be directly applied to the process of confirmation.

Radiation products also belonging to medical device, which may also involve instrumentation rules, should be checked separately. The product report or accession number does not replace the agent arrangement, nor does it indicate FDA approval. I'll see you in the direction.Radiation product applicability assessment。

II. What service boundaries should be identified before selecting an agent?

  • Practically accessible:Accreditation, actual address of the United States, telephones, mailboxes and emergency contact arrangements.
  • The duties are clear:The scope of the commission is confirmed by distinguishing between the designation of agents, the translation of documents, the registration submission, the technical declaration and the work of the importer.
  • Information can be handed over:Agreement on FDA forwarding, business feedback, file retention, and mode of handover after termination of service.
  • Business retention management capacity:Know who manages the registered accounts and records, keeps confirmation information and avoids that only external service providers possess key records.

III. What information is recommended before processing or changing?

  • Legal name of the enterprise and facility in English, actual address, product type and activity.
  • Existing records of registration, listing or product reporting, and applicable facility identification information.
  • The contact details of the original agent, the new agent and the arrangements to enter into force.
  • Daily and emergency contacts, account privileges and historical FDA transactions within the enterprise.
  • Specific tasks to be entrusted, duration of service, cost range and termination requirements.

Changes are made by confirming that the new agent has accepted the commission, updating the information in accordance with the systems and rules to which he belongs, completing the application of the confirmation and retaining the record. The 10 working days of medical device agree to confirm that the rules cannot serve as a uniform processing cycle for food, medicine or cosmetics.

IV. How are the processing cycles and costs judged?

The timing of preparation depends on the integrity of the information, the authority to account, the transfer of the original agent and the response of the new agent. Official processing or confirmation mechanisms vary from industry to industry and should be evaluated on a case-by-case basis, and it would not be appropriate to commit to a single completion date for all categories.

Agent service costs are usually agreed upon according to the scope and duration of the commission and should be shown separately as registration of the facility, user fees, declarations or third-party costs. If you just need to compare industry requirements, you can check them first.U.S. agent service overview; Industry service pages provide the applicable cycle, the cost composition and the associated next single entrance.

V. CURRENT ISSUES

Can United States importers act as agents?It should be judged by the qualifications and actual authorization of the industry to which it belongs, and the fact that the other party is an importer does not imply that it has accepted the duties of agent.

Can a company provide proxy services for multiple industries?There is a need to meet industry requirements and to complete the designation or confirmation thereof. Registration in one industry does not automatically cover other industries.

Does the agent assume full product compliance responsibility?No, I won't. Manufacturers, importers, labelers and other duty-bearers still have to fulfil their obligations; Nor is a contractual agreement a substitute for an applicable statutory obligation.

VI. Official sources and processing entrances

Before evaluating the service, please describe the product, the role of the enterprise and the records available. ALREG may thus assist in the identification of applicable matters, information gaps and specific terms of reference.

View industries U.S. agency services

Official data checks and updates: 2026-11-06. Author: Mr. Otsun; Audit: Mr. Toto. This paper is used to describe general compliance information, requiring that the facts of the business be judged against the current official rules.

Continue reading and preparation

Further consolidation of project information is availableFDA U.S. agent service mastery; The scope, processing cycles and costs are shown on the corresponding service page.